In short
Podcast Summary: WSJ Your Money Briefing - Episode on AI Deals, Trump on Pharma, Banks Split
Episode Overview
- Title: What’s News in Markets: AI Deals, Trump on Pharma, Banks Split
- Host: Francesca Fontana
- Date: October 18, 2023
- Description: The episode discusses the latest movements in stock markets relating to AI dealmaking, President Trump's comments on weight-loss drugs, and the performance of major U.S. banks following their quarterly reports.
---
Key Topics Covered
- Market Movements
- Overall Performance:
- Dow Jones: +1.6%
- S&P 500: +1.7%
- Nasdaq: +2.1%
- Factors Influencing the Market:
- Initial optimism due to easing trade war fears between the U.S. and China.
- Positive quarterly earnings reports from major banks indicating a strong U.S. economy.
- AI Dealmaking
- Broadcom and OpenAI:
- Broadcom entered a multi-billion dollar deal to create AI chips for OpenAI, which is developing custom computing systems.
- OpenAI's total computing capacity agreement now stands at 26 gigawatts, enough to power New York City during peak summer demands.
- Stock Performance:
- Broadcom shares rose by 9.9% on Monday and maintained gains.
- Walmart's Partnership with OpenAI:
- Walmart will sell products through an AI chatbot, enhancing customer experience.
- Stock Performance:
- Walmart shares increased by 5.8% over the week.
- Health-Related Stocks
- Hims & Hers:
- Shares jumped 16% after announcing new menopause care services, which could significantly boost revenue.
- Impact of Trump's Comments on Pharma Stocks:
- President Trump criticized current pricing of weight-loss drugs, suggesting potential decreases in costs.
- Stock Impact:
- Novo Nordisk: -3.1% on Friday, -4.5% for the week.
- Eli Lilly: -2% on Friday, -3.7% for the week.
- U.S. Banking Sector
- Performance of Major Banks:
- The six largest U.S. banks reported nearly $41 billion in profits, a 19% increase year-over-year.
- Stock Performance Highlights:
- Wells Fargo: +7.3%
- Bank of America: +5.4%
- Morgan Stanley: +4.5%
- Citigroup: +3.3%
- Goldman Sachs: -1.8%
- JPMorgan: -1.1%
---
Conclusion
- The episode provides a comprehensive snapshot of the factors driving stock movements in the current market, including the influence of AI advancements, health industry dynamics, and the robust performance of major U.S. banks. The discussions highlight how external comments and corporate earnings shape investor sentiment and market trends.
---
Additional Resources
- WSJ Markets A.M. Newsletter: For more insights and daily updates on financial markets.
- The Score Column: For detailed reporting on stock movements and analysis in the Wall Street Journal's Exchange section.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:00Millions of Americans use credit cards to purchase goods every day. The Durbin Marshall credit card mandates put the secure transactions you rely on at risk, leaving you vulnerable to hackers and foreign cyber criminals that want your data. Hackers win. You lose. Guard your card before it's too late. Tell Congress your data security is not for sale and oppose the Durbin Marshall credit card mandates. Paid for by Electronic Payments Coalition. Hey, listeners, your money briefing is on a break, but we'll be back with more personal finance information for you in the future. Until then, here's the news moving markets this week.
0:43Hey, listeners, it's Saturday, October 18th. I'm Francesca Fontana for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. It was an up and down week for the markets. On Monday, stocks were regaining ground thanks to comments from the Trump administration that eased investors' fears of a revived trade war with China. And this optimism in the market was further stoked by strong quarterly reports from banks that kicked off earnings season. The big picture takeaway there? America's biggest bankers said that the economy is solid, the U.S.
1:22consumer is healthy, and they haven't seen much change in recent months. and that sent investors cheering on Wednesday. Then Thursday came along, and the mood soured a bit on worries about the health of regional banks. So, how did it all shake out? Well, on a weekly basis, the Dow ended 1.6 % higher, the S &P gained 1.7%, and the Nasdaq rose 2.1%.
1:53First up, let's go through some of the big AI news from this week. Let's talk about the chipmaker Broadcom, which got a boost from its new multi-billion dollar deal with OpenAI, the startup behind ChatGPT. The two are working together to develop and deploy custom AI chips and computing systems as part of this massive deal. And we've talked on this podcast recently about OpenAI's big announcements with NVIDIA, Advanced Micro Devices, and now Broadcom. This one data point I found really highlights just how massive these deals are. Apparently, the total scale of computing capacity that OpenAI's agreed to buy is now 26 gigawatts.
2:38That's enough power to meet the summer electricity needs of New York City more than two times over. Broadcom shares jumped 9.9 % on Monday and held on to most of those gains throughout the week. And here's another chat GPT headline from this week. Walmart will soon be selling its products right within the AI chatbot. The retail giant's partnership with OpenAI will let U.S.-based users purchase nearly everything that they could get from the Walmart website, except for fresh food. And Walmart shares ended up gaining 5 % on Tuesday and, on a weekly basis, rose 5.8%.
3:27Next up, let's look at some health-related stocks making moves this week. Hims & Hers shares jumped 16 % on Wednesday on the news that the telehealth company will now offer menopause and perimenopause care. Hims & Hers said it expects the new specialty to help Hers, its women's health unit, to surpass$1 billion in annual revenue next year. Now let's jump to Friday's session. Pharma stocks Novo Nordisk and Eli Lilly really needed a shot in the arm. after comments from President Trump the day before sent their shares falling. While speaking in the Oval Office, Trump said that the out-of-pocket cost of Ozempic could fall to$150.
4:10For reference, Ozempic currently has a U.S. list price of nearly$1 ,000 a month. Now remember, Novo Nordisk makes Ozempic, as well as another weight loss drug, Wagovi, and Eli Lilly sells similar drugs, Manjaro and Zepbound. Now, these drugs costs are still apparently being negotiated, so this is just talk, so to speak. But the pricing concerns were enough to send U.S.-traded shares of Novo Nordisk down 3.1 % on Friday, losing 4.5 % for the week. And for Eli Lilly, the stock fell 2 % on Friday, and on the week, lost 3.7%.
4:50Last but not least, let's swing back to America's big banks. The six largest banks said they raked in almost$41 billion in profit in the past three months. That's a 19 % increase from last year. So how did the big six finish the week after all of the market's ups and downs? Well, in the number one spot was Wells Fargo, which gained 7.3%. Three more of the stocks managed to end the week in the green. Bank of America rose 5.4%, Morgan Stanley rose 4.5%, and Citigroup added 3.3%. And two of them ended with losses for the week. Goldman Sachs fell 1.8%, and JPMorgan lost 1.1%.
5:37And now you know what's news in markets this week. You can read about more stocks that moved on the week's news in The Score, my column in the Wall Street Journal's Exchange section. Today's show was produced by Zoe Colkin with Deputy Editor Chris Sinsley. I'm Francesca Fontana. Have a great weekend, and I'll see you next Saturday.
6:05Nearly home. Isn't home where we all want to be? Reba here for Realtor.com, the pro's number one most trusted app. A dream home isn't a dream home if it comes with a nightmare commute. That's why Realtor.com has Real Commute, so you can search by drive time. Download the Realtor.com app today, because you're nearly home. Make it real with Realtor.com. Pro's number one most trusted app based on August 2025 proprietary survey.
From the publisher
How did the week’s AI dealmaking affect stocks? And why did President Trump’s comments on weight-loss drugs hurt pharma shares? Plus, how did the big six U.S. banks finish out the week after strong quarterly reports? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
